University of Pittsburgh

Vimeo Appoints Philip Moyer as New Chief Executive Officer

Retrieved on: 
Thursday, April 4, 2024

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Vimeo (NASDAQ: VMEO), the leading video platform for businesses, today announced the appointment of Philip Moyer as Chief Executive Officer and member of the Board of Directors, effective April 8, 2024.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Vimeo (NASDAQ: VMEO), the leading video platform for businesses, today announced the appointment of Philip Moyer as Chief Executive Officer and member of the Board of Directors, effective April 8, 2024.
  • Adam Gross, the Company’s Interim Chief Executive Officer and member of the Board, will remain on the Board after the transition.
  • “I’m thrilled to join as CEO of Vimeo, a platform that revolutionizes how millions engage with video content worldwide,” said Moyer.
  • On Monday, May 6, 2024 at 5:00pm ET, Vimeo will live stream a video conference which will include Philip to answer questions regarding its first quarter results.

Brain & Behavior Research Foundation Awards Distinguished Investigator Grants Valued at $1 Million to 10 Scientists Pursuing Innovative Mental Health Research

Retrieved on: 
Thursday, April 4, 2024

New York, April 04, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) today announced it is awarding Distinguished Investigator Grants valued at $1 million to 10 senior-level scientists who are conducting innovative projects in neurobiological and behavioral research.

Key Points: 
  • New York, April 04, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) today announced it is awarding Distinguished Investigator Grants valued at $1 million to 10 senior-level scientists who are conducting innovative projects in neurobiological and behavioral research.
  • By funding transformative research focused on new ways to prevent, diagnose, and treat psychiatric disorders, our Distinguished Investigator Grants are encouraging established scientists to continue advancing our understanding of mental illness and disorders of brain and behavior,” says Jeffrey Borenstein, M.D., President and CEO of the Brain & Behavior Research Foundation.
  • The ground-breaking work of the Distinguished Investigator Grant recipients will bring hope and healing to people and families impacted by mental illness.
  • We applaud these scientists for their extraordinary dedication, innovation, and leadership.”
    Recipients of the Distinguished Investigator Grants are full professors at research institutions in the United States and abroad.

Greater Pittsburgh Festival of Books Releases Author Lineup, Opens Registration

Retrieved on: 
Wednesday, April 3, 2024

Pittsburgh, April 03, 2024 (GLOBE NEWSWIRE) -- Today, the Greater Pittsburgh Festival of Books announced registration is open for its third annual event, happening on May 11, 2024 on the campus of the Pittsburgh Theological Seminary in East Liberty.

Key Points: 
  • Pittsburgh, April 03, 2024 (GLOBE NEWSWIRE) -- Today, the Greater Pittsburgh Festival of Books announced registration is open for its third annual event, happening on May 11, 2024 on the campus of the Pittsburgh Theological Seminary in East Liberty.
  • Specially planned this year, the event will focus a portion of its programming on stories about Pittsburgh – and the greater Pittsburgh area – by hometown authors.
  • The Festival will be held from 10 a.m. to 5 p.m. on Saturday, May 11 at 616 North Highland Avenue, Pittsburgh.
  • The Festival is made possible thanks to support from sponsors including Carnegie Library of Pittsburgh, The Jack Buncher Foundation, KDKA and others.

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer

Retrieved on: 
Thursday, March 28, 2024

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that Daniel Vlock, M.D., has been appointed as the company’s Chief Medical Officer.

Key Points: 
  • BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that Daniel Vlock, M.D., has been appointed as the company’s Chief Medical Officer.
  • Dr. Vlock is a medical oncologist with over 25 years of industry experience and 15 years in academia, including renowned institutions Yale University, University of Pittsburgh, and Harvard University.
  • While at Pharmacia, Dr. Vlock ran the Celebrex Oncology program involving two pivotal clinical trials and over 3,500 patients.
  • Dr. Vlock initially will serve on a part-time basis through TransCode’s arrangement with BioBridges LLC, a life sciences consulting company.

Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging

Retrieved on: 
Friday, February 23, 2024

Dr. Abdel-Mohsen investigates what drives this rapid aging and how to create ways to slow down biological aging and improve health.

Key Points: 
  • Dr. Abdel-Mohsen investigates what drives this rapid aging and how to create ways to slow down biological aging and improve health.
  • A prime suspect in this aging puzzle is the gut microbiome and its potential leakage into the bloodstream.
  • The Abdel-Mohsen lab investigates how gut leakage can impact the immune system and lead to chronic inflammation, which may accelerate aging.
  • Their analysis revealed a significant connection between disrupted gut microbiomes, increased intestinal permeability (leaky gut), and faster biological aging.

InScribe Alongside A Guest Panel Receives Student Support and Success Best-in-Track Award at OLC Innovate

Retrieved on: 
Thursday, March 7, 2024

DENVER, March 7, 2024 /PRNewswire-PRWeb/ -- InScribe Education is delighted to share our achievement alongside a distinguished guest panel in receiving the Best-in-Track Award for Student Support and Success at the OLC Innovate 2023 conference. This accolade celebrates the most impactful presentations, as chosen by conference attendees.

Key Points: 
  • The Best-in-Track Award for Student Support and Success at OLC Innovate 2023 was awarded to InScribe for their timely session on fostering a sense of belonging for online learners.
  • DENVER, March 7, 2024 /PRNewswire-PRWeb/ -- InScribe Education is delighted to share our achievement alongside a distinguished guest panel in receiving the Best-in-Track Award for Student Support and Success at the OLC Innovate 2023 conference .
  • InScribe warmly congratulates our panelists and appreciates their vital contributions to this session.
  • On behalf of the entire panel, InScribe extends our gratitude to the OLC for recognizing our hard work, innovation, and dedication to improving the online learning experience.

Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK

Retrieved on: 
Monday, February 26, 2024

WEXFORD, Pa., Feb. 26, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced that it has expanded its exclusive license agreement with the University of Pittsburgh to include autoimmune indications as part of its ongoing development of SNAP-CAR T and SNAP-CAR NK.   This amended agreement builds upon the original exclusive license agreement with the University of Pittsburgh for SNAP-CAR T Cells, a "universal" CAR T technology platform designed to target multiple antigens simultaneously and potentially address a range of hematologic and solid tumors, and a recent amendment to the agreement for SNAP-CAR NK, an allogeneic natural killer (NK) cell therapy platform.

Key Points: 
  • WEXFORD, Pa., Feb. 26, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced that it has expanded its exclusive license agreement with the University of Pittsburgh to include autoimmune indications as part of its ongoing development of SNAP-CAR T and SNAP-CAR NK.
  • Autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis, are known to result from autoreactive B cells.
  • "We are again excited to expand our license with Coeptis," said Jason Lohmueller, Ph.D., Assistant Professor of Surgery and Immunology in the Division of Surgical Oncology Research, University of Pittsburgh.
  • According American Autoimmune Related Disease Association , there are more than 100 autoimmune diseases impacting 1 in every 5 Americans, 75% of whom are women.

Ads, food and gambling galore − 5 essential reads for the Super Bowl

Retrieved on: 
Friday, February 9, 2024

I didn’t get a pass to media day, so I didn’t get a chance to ask Chiefs head coach Andy Reid about how he tends to his mustache.

Key Points: 
  • I didn’t get a pass to media day, so I didn’t get a chance to ask Chiefs head coach Andy Reid about how he tends to his mustache.
  • But my colleagues and I were able to ask an all-pro lineup of scholars to write about a range of football-related topics, from the partisan food divide to the numbers behind the biggest gambling bonanza in league history.

1. Flag, you’re it

  • A year ago, league officials decided to shake up the annual showcase.
  • It would no longer be a tackle football game.
  • But Woods points to a gender divide and a political divide that could end up clouding the sport’s future.

2. X’s, O’s and Z’s

  • In 2011, former NFL cornerback Sam Shields was a rookie playing for a Green Bay Packers team that had made the Super Bowl.
  • The night before the big game, he tossed and turned.
  • Something tells me I’d be a lot like Shields.

3. Going all in on gambling

  • Or maybe you’re betting on Reba McEntire’s national anthem to last longer than 90.5 seconds.
  • The country’s gambling mania has been aided, in part, by the Supreme Court’s 2018 ruling that overturned a federal ban on sports betting.
  • The NFL has gone all in on its embrace of gambling, forging billion-dollar partnerships with the country’s top sportsbooks.
  • Read more:
    The Super Bowl gets the Vegas treatment, with 1 in 4 American adults expected to gamble on the big game

4. At least they aren’t serving donkey meat

  • And even the Super Bowl – one of the few communal events left in a polarized, atomized nation – can’t avoid the creep of partisanship.
  • Maybe you could just serve salmon – a food that, according to Dyck and Pearson-Merkowitz’s research, is “resistant to partisan cues.” Grim times, indeed.
  • Read more:
    Super Bowl party foods can deliver political bite – choose wisely

5. ByeDaddy

  • That’s one reason companies are willing to fork over so much cash for a coveted slot – as much as US$7 million for a 30-second spot.
  • Ferrell point out, many regulars on the airwaves of the Super Bowl, such as GoDaddy and Ford, are missing from this year’s lineup.
  • Read more:
    Super Bowl ads: It's getting harder for commercials to score with consumers

    This story is a roundup of articles from The Conversation’s archives.

ZOLL Foundation Marks Ten Years of Providing “Seed” Grants to Young Medical Researchers Around the World

Retrieved on: 
Tuesday, January 23, 2024

To date, the ZOLL Foundation has awarded more than $6 million in grants to 150 individuals and their respective institutions in 20 countries on six continents.

Key Points: 
  • To date, the ZOLL Foundation has awarded more than $6 million in grants to 150 individuals and their respective institutions in 20 countries on six continents.
  • Now in its tenth year, the ZOLL Foundation expects its total awards to exceed $7 million in 2024.
  • “The ZOLL Foundation’s vision is that our seed grants will support follow-on research that improves care and enhances training in clinical practice,” said Ward Hamilton, President of the ZOLL Foundation Board of Directors.
  • Early support by the ZOLL Foundation was incredibly valuable for me as an investigator.

The Advanced Leadership Institute and Carnegie Mellon University Announce The 2024 Cohort of The Executive Leadership Academy

Retrieved on: 
Friday, January 26, 2024

PITTSBURGH, Jan. 26, 2024 /PRNewswire/ -- The Advanced Leadership Institute (TALI) and Carnegie Mellon University Tepper School of Business (CMU) are pleased to announce the 2024 Executive Leadership Academy cohort.

Key Points: 
  • PITTSBURGH, Jan. 26, 2024 /PRNewswire/ -- The Advanced Leadership Institute (TALI) and Carnegie Mellon University Tepper School of Business (CMU) are pleased to announce the 2024 Executive Leadership Academy cohort.
  • Since 2019, TALI has engaged CMU Tepper Executive Education to assist with developing and delivering content that educates and expands diverse leadership from Pittsburgh through TALI's signature program — the Executive Leadership Academy.
  • The 2024 Executive Leadership Academy cohort furthers our mission and vision," says Evan Frazier, President and CEO, The Advanced Leadership Institute.
  • TALI and CMU will welcome the new cohort at the 2024 Executive Leadership Academy Kick-Off Program and Reception on January 26, 2024.